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Abstract 
As there are increasing evidences that human diabetes induces cardiovascular 
dysfunction, we investigated the type 2 diabetes-induced endothelial dysfunction in the 
early and late-stage Goto-Kakizaki (GK) rat aorta. We performed organ bath studies, 
and examined the changes in expression levels of muscarinic M3 receptor, endothelial, 
inducible and neuronal nitric oxide synthetase (eNOS, iNOS and nNOS, respectively) 
mRNAs in the rat aorta utilizing real-time polymerase chain reaction in 12-weeks-old 
and 70-week-old GK rats as well as in age-matched Wistar rats. In the 12-week-old GK 
rat aorta, a significant increase in norepinephrine-induced contraction and a significant 
decrease in acetylcholine-induced relaxation as well as significant increases in 
expression levels of muscarinic M3 receptor and eNOS and a significant decease in 
nNOS mRNAs were observed compared to age-matched controls. In the older GK rat 
aorta, significant decreases in acetylcholine- and nitroglycerine-induced relaxations as 
well as significant decreases in the expression levels of muscarinic M3 receptor, eNOS, 
iNOS and nNOS mRNAs were observed compared to those in the younger GK rats. In 
contrast, although significant decreases in acetylcholine and nitroglycerine-induced 
relaxations were observed, the expression levels of muscarinic M3 receptor, eNOS, 
iNOS and nNOS mRNAs in the older Wistar rats aorta were unchanged, increased, 
increased and decreased, respectively, compared to the younger Wistar rat aorta. These 
results indicate that endothelial dysfunction in the rat aorta progresses with age and 
development of diabetes condition, and that decreased relaxations in the late-stage rat 
aorta may be due to these alterations. 
Introduction 
It has been estimated that there will be 200-300 million cases of metabolic syndrome 
including type 2 diabetes in Western society by 2010. Moreover, all characteristics of 
the metabolic syndrome are known to be significant risk factors for cardiovascular 
diseases [1]. Although several studies have examined vascular dysfunction in patients 
with diabetes or in animal models of diabetes, there are only limited data describing 
vascular dysfunction with age of type 2 diabetes animals [2]. Endothelial cells in the 
aorta play an important roll in the control of vascular smooth muscle and 
auto-regulation of vascular homeostasis through the release of a variety of 
vasconstricting and vasodilating autacoids, including thromboxan, prostacyclin, nitric 
oxide (NO) [3,4]. In 1980, Furchgott and Zwadaki reported that the relaxation of 
isolated rabbit aorta and other arteries induced by acetylcholine (ACh) and other 
agonists for muscarinic receptors depended on the presence of endothelial cells in the 
preparation [5]. In the diabetic rat aorta, endothelium-dependent vasodilatation is 
impaired, largely due to the production of vasoconstrictor prostanoids and/or 
oxygen-derived free radicals [6]. It is also thought that hyperglycemia, oxidation of 
low-density lipoprotein, hypertension, hypertriglyceridemia and autonomic neuropathy 
promote vascular dysfunction in diabetes patients [6]. 
It has been reported that NO derived from endothelial cells is an important mediator of 
vasodilatation [7]. Abnormal release of, or response to, NO has been proposed to 
contribute to vascular and endothelial dysfunction in the diabetic state [8]. Furthermore, 
it has been reported that the muscarinic M3
The mildly diabetic Goto-Kakizaki (GK) rat, which is obtained by selective breeding 
 receptor mainly mediates vasodilatation via 
the actions of eNOS in the rat aorta [9,10].  
of individuals with glucose intolerance from a non-diabetic Wistar rat colony, is a 
widely accepted, genetically determined rodent model for human type 2 diabetes [11]. 
Impaired response to glucose both in vivo and in isolated islets of the young GK rat [12] 
and raised plasma levels of glucagons in GK rats are common features of human type 2 
diabetes and contribute to its development [13]. GK rats are characterized by early mild 
insulin resistance, followed by abnormalities in insulin secretion and modest 
hyperglycemia [14], and this model has been shown to be useful for studying type 2 
diabetic complications [15]. 
Because information concerning age-related endothelium dysfunction in diabetic type 
2 animal models is limited, we conducted a longitudinal examination using this model. 
In order to clarify the long-term influence of diabetes type 2-induced vascular 
dysfunction and reveal its molecular mechanisms, we investigated aortic relaxation and 
contraction as well as the aortic expression levels of the mRNAs for muscarinic M3
 
 
receptor and NO synthase (NOS) of three isotypes (eNOS, iNOS, nNOS) in the early- 
and late-stage GK rat. 
Materials and methods 
Animals 
All animal experiments were performed in accordance with the guidelines 
established by the Tottori University Committee for Animal Experimentation. 
Six-week-old male GK and Wistar rats were purchased from SLC (SLC, Shizuoka, 
Japan). All groups were kept under identical conditions, with free access to food and 
drinking water. The rats were divided randomly into 4 groups (n=6–8 each): groups A 
and B consisted of 12-week-old Wistar and GK rats respectively, and groups C and D 
consisted of 70-week-old Wistar and GK rats, respectively. Upon reaching 12 or 70 
weeks of age, the rats were sacrificed with an overdose of pentobarbital (60 mg/animal, 
i.p.). Blood samples were collected from the vena cava. The aorta was removed from 
each animal and immediately used for functional studies or frozen at -80°C until used to 
measure the expression levels of muscarinic M3
 
 receptor and NOS mRNAs.  
Serum glucose and insulin measurement 
Serum glucose concentrations in the experimental rats were measured by the 
hexokinase method using a Glucose CII kit (Wako Pure Chemical, Osaka, Japan) 
according to the manufacturer's instructions. Insulin concentrations were measured by 
ELISA using a Rat Insulin ELISA kit according to the manufacturer's instructions 
(Mercodia AB, Uppsala, Sweden).  
  
In vitro organ bath experiments  
The functional studies were performed according to our previous report [16]. 
The thoracic aortas were cut into approximately 3-mm-long ring segments. Each ring 
was suspended on a wire hook in an organ bath (25 ml) containing Krebs–Henseleit 
solution, and bubbled with 5% CO2 and 95% O2 (37°C). One hook was suspended from 
a transducer (Mitutoyo, Tokyo, Japan). Each ring was equilibrated unstretched for 30 
min. A load of 0.5 g was applied to each ring by micrometer adjustment, and the load 
was readjusted to this level 30 min later. Changes in the tone were recorded by a force 
transducer on a personal computer (Macintosh G3; Apple Computer, Cupertino, CA) by 
use of Chart v 3.6.9 software and a PowerLab/16sp data acquisition system (AD 
Instruments, Castle Hill, Australia). Following a 30-min period of equilibration, the 
rings were exposed to 100 mM KCl. In the aorta rings, the contractile response to 
norepinephrine (1×10−9– 3×10−6 M) was determined cumulatively. After a 30-min 
washout period, propranolol (1×10−6 M) was added to prevent the involvement of 
β-adrenoceptors. Endothelium-mediated relaxation was measured as a 
concentration–response curve to acetylcholine (1×10−8–3×10−5 M) in rings contracted 
with the submaximal dose of norepinephrine (3×10−7 M). Endothelium-independent 
aortic relaxation in response to nitroglycerin (NTG) (1×10−6
 
 M) was also measured in 
the rings. 
Real-time polymerase chain reaction (quantification of muscarinic M3
Expressions of muscarinic M
 receptor, 
eNOS, iNOS and nNOS mRNAs) 
3 receptor, eNOS and iNOS and nNOS mRNAs in 
the experimental aorta were measured by real-time polymerase chain reaction (PCR) 
method. The mRNAs were purified using an RNeasy Mini Kit (Quiagen, Valencia, CA) 
according to the manufacturer's instructions. A reverse transcriptase mixture (28 μl) 
containing 2 μg of total RNA was made and incubated at 37°C for 60 min. Fifteen μl of 
the master mix was used for the real-time PCR, which was carried out using a 
LightCycler thermal cycler system with a LightCycler-FastStart Hybridization Probe kit 
according to the manufacturer's instructions (Roche Diagnostics, Tokyo, Japan). The 
muscarinic M3
 
 receptor (GeneBank Accession: NM_012527) primers and probe 
sequences were as follows: primer forward (1227–1245: 5′-GGACTGTGGATGT 
GGAGAG-3′), primer reverse (1358–1375: 5′-CGAGGAGTT GGTGTCAGA-3′); and 
probe forward (1267–1284: 5′-CCA GAAGAGCATGGGTGATGGTGACAACT-3′), 
probe reverse (1286–1325: 5′-XGTCAGAAGGATTTCACCAAGC-TTC 
CCATCCT-3′). The primer and probe of the β-actin (GeneBank Accession: 
NM_031144), eNOS (GeneBank Accession: AJ011116), iNOS (GeneBank Accession: 
D44591) and nNOS (GeneBank Accession: NM_052799) were from a 
LightCycler-Primer/Probe Set (rat) (Roche Diagnostics, Tokyo, Japan). A total of 5 μl 
of template was used for the sample. The specificity of the reaction was confirmed by 
2% agarose gel electrophoresis. The primers for the β-actin gene were used as the 
internal standard and gene levels were analyzed by real-time PCR using the same 
reverse transcriptase mixture. 
Measurement of NO 2-NO 3 concentrations in the aortas 
As the final products of NO in vivo are NO2-NO3, NO2-NO3 concentrations in 
the aortas of 70-week-old GK and Wistar rats were measured by means of the Griess 
method. In brief, the tissue was homogenized with a Multi-beads Shocker®, and then 
centrifuged at 10,000 ×g for 20 min. The supernatant solution was centrifuged again at 
100,000 ×g for 30 min and then was used for the NO2-NO3 assay. 
NO2-NO3 concentrations were measured by colorimetric assay according to the 
manufacturer’s instructions (Nitrate/ Nitrite Colorimetric Assay Kit; Cayman Chemical 
Co., Ann Arbor, MI). The absorbance was measured at 540 nm. The concentrations were 
standardized per amount of protein in the tissue. The protein was measured using a 
commercial kit (Protein Assay Rapid Kit Wako; Wako Pure Chemical, Osaka, Japan). 
 
Data analysis 
The data for the contractions induced by norepinephrine were normalized by 
the contractions induced by 100 mM KCl. The relaxation responses with submaximal 
contraction caused by 3×10−7 M norepinephrine were expressed as percentages of its 
contraction. The EC50 and Emax values were obtained using a Macintosh computer (G3) 
loaded with Chart v3.6.9 software and a PowerLab/16sp data acquisition system. The 
EC50 values were calculated as geometric means, whereas the Emax values were 
calculated as arithmetic means. The expressions of muscarinic M3
 
 receptor, eNOS, 
iNOS and nNOS mRNAs were quantified according to the expression of β-actin mRNA 
in the experimental rat aorta. A statistical comparison of differences between groups 
was performed using analysis of variance and Fisher's multiple comparison tests. 
P<0.05 was regarded as the level of significance.  
Drugs and chemicals 
Propranolol and norepinephrine were purchased from Sigma (St. Louis, MO), 
and NTG (millisrol®) was purchased from Nihonkayaku Co., Ltd. (Tokyo, Japan). All 
other chemicals were available commercially and of reagent grade. 
Results 
Animals 
The data obtained for body weight and serum concentrations of insulin and 
glucose in the experimental animals are shown in Table 1 and Figure 1. The GK rats 
showed significantly smaller weight gain during the experimental period compared to 
the Wistar rats. The serum glucose concentrations were significantly elevated in the GK 
rats compared to the Wistar rats both in the younger and the older animals (Table 
1). The serum insulin levels in 12-week-old GK diabetic rats were significantly higher 
than those in 12-week-old Wistar rats, while the 70-week-old GK diabetic rats had 
significantly lower serum insulin levels than did the control rats. 
 
In 70-week-old Wistar 
rats, the serum insulin levels were statically significant larger than those in the younger 
Wistar rats, and in 70-week-old GK rats, the serum insulin levels were statistically 
smaller than those in younger GK rats. 
In vitro organ bath experiments  
 The maximum contraction (Emax) values and the EC50 values for the contractile 
responses of the aorta rings to norepinephrine and KCl (100 mM) were determined. The 
Emax values in response to norepinephrine in the younger GK rats were significantly 
higher than those in age-matched Wistar rats, while the Emax values in the older GK rats 
were similar to those in age-matched Wistar rats (Table 2). The EC50 values in the older 
GK rats were significantly lower than those in the younger GK rats and age-matched 
Wistar rats. The maximum relaxation values and the EC50 values in response to ACh 
are shown in Table 2. In the aortic rings contracted by norepinephrine (3×10−7 M), ACh 
produced relaxation in a dose-dependent manner (Fig. 2). The maximum relaxation 
tension in response to ACh in the 12-week-old GK rats was significantly higher than 
those in the age-matched Wistar rats. The maximum relaxation tension in response to 
ACh in the 70-week-old GK rats was significantly higher than those in the age-matched 
Wistar rats and in the 12-week-old GK rats (Fig.2). The maximum relaxation values in 
response to ACh in the 70-week-old Wistar rats were significantly lower than those in 
the 12-week-old Wistar rats (Table 2). The EC50 values in response to ACh in the older 
Wistar and GK groups were similar to those
 
 in the younger groups (Table 2). 
NTG–induced endothelium-independent relaxation was decreased in 70-week-old rats 
compared to the 12-week-old rats both in the GK and Wistar rats, while there were no 
significant differences in NTG-induced relaxation between the younger GK and Wistar 
rats (Table 2).  
Quantification of muscarinic M3
 The expression levels of muscarinic M
 receptor, eNOS, iNOS and nNOS mRNAs in the 
aorta 
3 receptor, eNOS, iNOS and nNOS 
mRNAs in the GK rat aorta are shown in Figure 3. The expression level of the 
muscarinic M3 receptor mRNA in the younger GK rats was significantly higher than 
that in the age-matched Wistar rats. While there was no significant difference of the 
expressions of muscarinic M3 receptor mRNA between older GK and Wistar rats, the 
expression level of the muscarinic M3 receptor mRNA in the older GK rats was 
significantly lower than that in the younger ones. The expression levels of the eNOS, 
iNOS and nNOS mRNAs in the older GK rat were significantly lower than those in the 
younger one. The expression level of eNOS mRNAs was significantly higher in the 
older Wistar rat than that in the younger one. The expression level of iNOS mRNAs in 
the older Wistar rat was significantly higher than that in the younger Wistar rat and that 
in older GK rat. The expression level of iNOS mRNAs in the older GK rat was 
significantly lower than that in the younger GK rat. The expression level of nNOS 
mRNA in the younger Wistar rat was significantly higher than that in younger GK rat. 
In contrast, the expression level of nNOS mRNA in the older Wistar rat was 
significantly lower than in the younger one. 
 
The expression level of nNOS mRNAs in 
the older GK rat was significantly lower than that in age-matched Wistar rat. 
NO 2-NO 3 concentrations in the late-stage GK and Wistar rats 
NO2-NO3
 
 concentrations in aorta samples of 70-week-old GK and 
70-week-old Wistar rats were 24.3 ± 2.6 nmol/mg protein and 18.1 ± 1.8 nmol/mg 
protein, respectively. However, the p value was 0.095, and subsequently the difference 
between the two groups was statistically non significant. 
Discussion 
The main findings of the present study are that in the late stage (70-week-old) 
GK rats, endothelium-independent relaxations were impaired compared to those in the 
younger (12-week-old) GK or age-matched Wistar rats, and that reduced expressions of 
eNOS, iNOS and nNOS mRNAs were observed in the old GK rats compared to the 
age-matched Wistar rats, resulting in a decline of relaxation directly via smooth 
muscle. 
Vascular dysfunction and cardiovascular diseases are major complications in 
diabetes mellitus, and are principally caused by endothelial dysfunction [18-20]. 
Although a number of studies have examined endothelial dysfunction in the metabolic 
syndrome and/or diabetes, few studies have examined the progression of vascular 
dysfunction in a long term fashion as these diseases develop [2, 21]. Long-term 
examination of endothelial dysfunction is necessary, because development of the 
metabolic syndrome and/or type 2 diabetes occur over months or years as they are 
Furthermore, in this study, we confirmed that 12-week-old GK rats were mild 
hyperinsulinemic and hyperglycemic, and that 70-week-old GK rats were modest 
hypoinsulinemic and hyperglycemic. Portha et al. (2009) proposed that the defective 
beta-cell mass and function in the GK model reflect the complex interactions of 
multiple pathogenic players: (i) several independent loci containing genes responsible 
for some diabetic traits (but not decreased beta-cell mass); (ii) gestational metabolic 
impairment inducing an epigenetic programming of the pancreas (decreased beta-cell 
neogenesis and/or proliferation) which is transmitted to the next generation; and (iii) 
loss of beta-cell differentiation due to chronic exposure to 
hyperglycemia/hyperlipidemia, inflammatory mediators, oxidative stress and to 
perturbed islet microarchitecture [17]. 
progressive diseases. 
In the present study, aortas from 70-week-old GK rats exhibited decreased 
endothelium-dependent relaxation in response to ACh in comparison with both 
age-matched Wistar rats and younger GK rats. These results are in agreement with 
previous studies conducted on the aorta of Zucker diabetic fatty (ZDF) rats. Oltman et al. 
(2006) showed that ACh-induced relaxation was attenuated in the aortas of 28- to 
40-week-old ZDF diabetic rats in comparison with the aortas of 8- to 12-week-old ZDF 
rats [2]. Additionally, Zhang et al. (2004) reported decreasing endothelial function over 
time (3 to 9 months of age) in the ZDF rat aorta [22]. In the present study, although 
there were no significant differences between 12-week-old GK and age-matched Wistar 
rats in regard to the maximum relaxations in response to NTG, significant decreases in 
the maximum relaxations produced by NTG in both 70-week-old GK and 70-week-old 
Wistar rats compared to the younger groups were observed. This finding might be 
attributable to the fact that diabetes impairs the endothelium relatively early in its 
progression, and affects the aortic smooth muscle later. Bitar et al. (2005) reported that 
there were no significant differences in the maximum relaxation in response to Ach 
between aortic rings from one-month-old GK rats and age-matched Wistar rats [23]. 
Both Sandu et al. (2000) and Witte et al. (2002) reported that aortas from rats with 
long-term GK diabetes show an impaired endothelium-independent relaxation [24, 25]. 
Our data are consistent with these previous reports. Hyperreactivity to endothelin 
(ET)-1 is an important issue in diabetic vascular dysfunction. Insulin resistance, an 
important component of type 2 diabetes, contributes to vascular responsiveness to 
vasoactive factors. The potent vasoconstrictor ET-1 is chronically up-regulated in 
diabetes [26]. Elgebaly et al. (2008) reported that vascular insulin resistance occurs in a 
nonobese model of diabetic GK rats and that both ETA and ETB receptor subtypes are 
involved in vascular relaxation to insulin [27]. The key factor in endothelial function is 
NO, which is generated via the constitutive eNOS. There are three distinct isoforms of 
NOS, and they have been shown to have different localizations and catalytic properties 
[28, 29]. The eNOS and nNOS enzymes are suggested to be important regulators of 
glucagon release [30]. nNOS functionally controls vascular homeostasis [28, 31, 32]. 
The expression of iNOS is only promoted when endothelial dysfunction occurs [28, 
31-33]. eNOS is constitutively expressed and essential for the control of vascular tone 
[34]. Thus, impaired NO synthesis and/or availability may result in endothelial and 
vascular wall dysfunction. In this study, we demonstrated that NO2-NO3 levels in the 
aortas of 70-week-old GK (group C) and age-matched Wistar rats (group D) were 
similar. Bitar et al (2005) suggested a possible mechanism of endothelial dysfunction in 
the GK diabetic rat. An enhancement in superoxide production and a diminution in NO 
bioavailability are evident in the GK rat. Diabetes produces a cascade of events 
involving production of reactive oxygen species from NADPH oxidase leading to 
oxidation of BH4
In our study, endothelium-dependent relaxation in 12-week-old GK rats was 
significantly decreased in comparison with the age-matched Wistar rats. In addition, the 
level of eNOS mRNA expression in 12-week-old GK rats was elevated compared to that 
in age-matched Wistar rats. Several other investigators have reported similar findings in 
GK rats. Bitar et al. 
 and uncoupling of NOS. This may promote the oxidative inactivation 
of NO with subsequent formation of peroxynitrate. An alteration in the balance of these 
bioactive radicals in concert play a potentially role in pathogenesis of diabetic 
endothelial dysfunction [23]. 
(2005) demonstrated that ACh-induced relaxation was markedly 
reduced and eNOS protein was significantly increased in GK rats compared to controls 
[23]. 
There have also been reports indicating that eNOS mRNA and protein levels in 
the aortic wall are increased in diabetic rats [19, 31, 37]. Cai et al. 
Lee et al. (2009) reported the presence of Akt-independent iNOS expression in the 
GK diabetic model. They noticed that the defective insulin-induced vasodilation 
observed in the diabetic vasculature can be restored by the overexpression of active Akt, 
which advocates a potential novel therapeutic strategy for treating diabetes [35]. 
Matsumoto et al. (2009) reported that up-regulation of ETA, a defect in ETB-mediated 
NO signaling, and activation of the MEK/ERK pathway together represent a likely 
mechanism mediating the hyperreactivity to ET-1 examined in GK diabetic rat 
mesenteric artery [36]. 
(2005) recently 
reported that, although total eNOS levels were increased, NO levels were significantly 
decreased in the aortas of diabetic mice [38]. These data suggest that diabetes may 
increase eNOS expression and reduce NO bioavailability in the vascular wall [34]. 
Furthermore, in the present study, we reported for the first time that eNOS mRNA 
levels were lower in older GK rats than in younger ones. Moreover, our report suggests 
that the expression levels of iNOS mRNA in 70-week-old Wistar rats were significantly 
increased compared to those in the younger Wistar rats. In contrast, expression levels of 
iNOS mRNA in GK rats in the late stage were significantly decreased compared to 
those in the younger GK rats. It is well known that iNOS is induced by inflammation 
and/or infiltration of neutrophils and that iNOS-derived NO exhibits a powerful 
protective activity under a cellular stress condition [38].  In various pathologic 
conditions, including diabetes mellitus, iNOS is expressed in atherosclerotic plaques 
and produces a large amount of NO and O2- locally, which results in production of 
oxidative products [38]. Recently, Ji et al. (2008)
In the 12-week-old GK rats, the expression levels of muscarinic M
 reported that increased levels of free 
radicals with a decrease of vascular endothelial growth factor and iNOS contribute to 
the progression of the pressure-overload hypertrophied heart to the failing heart [39]. 
3 receptor 
mRNAs were significantly higher than those in the age-matched Wistar rats. We 
previously reported a similar pattern in the expression levels of muscarinic M3 receptor 
mRNAs in streptozotocin-induced diabetic rat aortas [16]. This up-regulation of 
muscarinic M3 receptor mRNAs may be related to a decrease in Ach in the early phase 
of diabetes. In the later stage of diabetes, the muscarinic M3
In conclusion, this study has demonstrated diabetes-related and age-related 
alterations in endothelial function, and expressions of muscarinic M
 receptor mRNA levels in 




 receptor, eNOS, 
iNOS and nNOS mRNAs in the aortas of GK rats and Wistar rats. 
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Figure legends 
Fig. 1: Changes of body weight during the experimental period. 
Data are shown as the means ±SEM for 6-8 animals in each group. *Significantly 
different from age-matched Wistar rats. 
 
Fig. 2: Endothelium-dependent relaxation of rat aortic rings in response to Ach (large 
panel). Inset: Contractions (means ± SEM) produced by norepinephrine (3×10−7 M) in 
each group (small panel). *) significantly different from age-matched Wistar group 
(group A vs group B, group C vs group D). †
 
) significantly different from younger group 
(group A vs group C, group B vs group D). (p<0.05). Data are shown as the means ± 
SEM for 6-8 animals in each group.  
Fig. 3: The expressions of muscarinic M3
*) significantly different between group (p<0.05). 
 receptor, eNOS, iNOS, and nNOS mRNAs 
normalized by β-actin mRNA in the aortas of GK rats 
 
 
Table.1 General features in the experimental rats. 
 
Body weight (g)   Serum glucose (mg/dl)         Serum insulin (μg/l) 
A   350.0 ?  4.9     153.4 ?  7.9   1.5 ?  0.3 
B  298.3 ?  5.4*   233.1 ?  12.3*   2.2 ?  0.4* 
C   561.3 ?  21.7†   132.2 ?  5.9    2.5 ?  0.3† 
D  424.3 ?  4.2*†   212.1 ?  8.3*     0.4 ?  0.1*† 
A: 12-week-old Wistar rats, B: 12-week-old GK rats, C: 70-week-old Wistar rats, 
D: 70-week-old GK rats. Data are shown ± SEM of six to eight determinations in 
each group. *)	 significantly different from age-matched Wistar group (group A 
vs group B, group C vs group D). †)	 significantly different from younger group 
(group A vs group C, group B vs group D). (p<0.05). 
 
Table 2. Data of contractile and relaxation studies in the rat aorta. 
 
Contraction                         Relaxation 
Norepinephrine                     ACh                      NTG 
Emax/KCl      EC50 (10-8M)         Maximum      EC50 (10-8M)        Maximum 
(100 mM)                           relaxation (%)                      relaxation (%) 
A   1.56 ± 0.03     9.06 ± 2.75       50.34 ± 2.38   5.85 ± 0.81      87.05 ± 1.82 
B   1.69 ± 0.03*   8.21 ± 1.68     39.74 ± 4.46*  5.44 ± 2.21      91.64 ± 1.19         
C   1.55 ± 0.05      5.36 ± 0.91       30.92 ± 2.33†  3.58 ± 1.04     76.09 ± 3.72† 
D   1.66 ± 0.04     2.30 ± 0.35*†      22.09 ± 4.08*†  3.36 ± 2.52     73.34 ± 2.77† 
 
A: 12-week-old Wistar rats, B: 12-week-old GK rats, C: 70-week-old Wistar rats, D: 70-week-old GK rats. Data are shown ± 
SEM of six to eight determinations in each group. *)	 significantly different from age-matched Wistar group (group A vs group 
B, group C vs group D). †)	 significantly different from younger group (group A vs group C, group B vs group D). (p<0.05).	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